drugset / Trial / NCT03587584
Liposomal Bupivacaine Interscalene Blocks for Rotator Cuff Repair
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare pain control after arthroscopic rotator cuff repair surgery using either liposomal bupivacaine or bupivacaine when injected in an interscalene block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care in these types of surgeries.
Timeline
- Start
- 2018-07-25
- Primary completion
- 2021-05-25
- Completion
- 2021-06-08
Outcome
Missed primary endpoint
paper LB added to bupivacaine interscalene blocks does not reduce opioid consumption within 72 hours following arthroscopic RCR. PMID 35190468 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 10 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 133 mg | Other |
Indications
No indication recorded.